WO2022112959A1 - Non-colouring turmeric formulation and a process for preparation thereof - Google Patents
Non-colouring turmeric formulation and a process for preparation thereof Download PDFInfo
- Publication number
- WO2022112959A1 WO2022112959A1 PCT/IB2021/060910 IB2021060910W WO2022112959A1 WO 2022112959 A1 WO2022112959 A1 WO 2022112959A1 IB 2021060910 W IB2021060910 W IB 2021060910W WO 2022112959 A1 WO2022112959 A1 WO 2022112959A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- turmeric
- formulation
- colouring
- granules
- comprised
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 185
- 235000003373 curcuma longa Nutrition 0.000 title claims abstract description 147
- 235000003392 Curcuma domestica Nutrition 0.000 title claims abstract description 143
- 235000013976 turmeric Nutrition 0.000 title claims abstract description 143
- 244000008991 Curcuma longa Species 0.000 title claims abstract description 130
- 238000009472 formulation Methods 0.000 title claims abstract description 112
- 238000004040 coloring Methods 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 title claims abstract description 41
- 230000008569 process Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 75
- 239000008187 granular material Substances 0.000 claims abstract description 68
- 235000020241 curcumin extract Nutrition 0.000 claims abstract description 48
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 27
- 239000008393 encapsulating agent Substances 0.000 claims abstract description 26
- 239000002552 dosage form Substances 0.000 claims abstract description 21
- 238000010410 dusting Methods 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 239000003925 fat Substances 0.000 claims description 25
- 239000011248 coating agent Substances 0.000 claims description 18
- 238000000576 coating method Methods 0.000 claims description 16
- -1 fatty acid esters Chemical class 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 15
- 239000002417 nutraceutical Substances 0.000 claims description 12
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 239000011230 binding agent Substances 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 239000001993 wax Substances 0.000 claims description 7
- 239000003085 diluting agent Substances 0.000 claims description 6
- 239000008299 semisolid dosage form Substances 0.000 claims description 6
- 239000007909 solid dosage form Substances 0.000 claims description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 239000001692 EU approved anti-caking agent Substances 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- 229940095602 acidifiers Drugs 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000003981 vehicle Substances 0.000 claims description 2
- 238000012505 colouration Methods 0.000 claims 1
- 244000163122 Curcuma domestica Species 0.000 description 27
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 26
- 235000019197 fats Nutrition 0.000 description 23
- 238000010186 staining Methods 0.000 description 16
- 239000003826 tablet Substances 0.000 description 13
- 235000012754 curcumin Nutrition 0.000 description 12
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 239000004148 curcumin Substances 0.000 description 11
- 229940109262 curcumin Drugs 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 229940032147 starch Drugs 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 5
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- OJFGQVZAISEIPG-IJIVKGSJSA-N tetrahydroxycurcumin Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C(O)=C1 OJFGQVZAISEIPG-IJIVKGSJSA-N 0.000 description 5
- 235000014375 Curcuma Nutrition 0.000 description 4
- 229930153442 Curcuminoid Natural products 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 229920002785 Croscarmellose sodium Polymers 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 241000234299 Zingiberaceae Species 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 238000012994 industrial processing Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- YQEMORVAKMFKLG-UHFFFAOYSA-N 2-stearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241001512940 Curcuma amada Species 0.000 description 2
- 235000018453 Curcuma amada Nutrition 0.000 description 2
- 235000003398 Curcuma aromatica Nutrition 0.000 description 2
- 241000388070 Curcuma caesia Species 0.000 description 2
- 235000008359 Curcuma caesia Nutrition 0.000 description 2
- 241001113213 Curcuma caulina Species 0.000 description 2
- 241000963421 Curcuma kwangsiensis Species 0.000 description 2
- 235000003397 Curcuma kwangsiensis Nutrition 0.000 description 2
- 241000463821 Curcuma leucorrhiza Species 0.000 description 2
- 240000005629 Curcuma phaeocaulis Species 0.000 description 2
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 2
- 241000963390 Curcuma wenyujin Species 0.000 description 2
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 2
- 240000009138 Curcuma zedoaria Species 0.000 description 2
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930182558 Sterol Chemical class 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229960005168 croscarmellose Drugs 0.000 description 2
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 2
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 239000010681 turmeric oil Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- ZIUSSTSXXLLKKK-KOBPDPAPSA-N (1e,4z,6e)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-KOBPDPAPSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- CRCHRNHFHJDFAA-FCXRPNKRSA-N (1e,6e)-1-(4-hydroxy-5-methoxycyclohex-3-en-1-yl)-7-(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione Chemical class C1C=C(O)C(OC)CC1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C(OC)=C1 CRCHRNHFHJDFAA-FCXRPNKRSA-N 0.000 description 1
- SSPCELDPIFWFOR-YPCIICBESA-N (1e,6e)-1-[4,5-dihydroxy-5-(trihydroxymethoxy)cyclohex-3-en-1-yl]-7-(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C2CC(O)(C(O)=CC2)OC(O)(O)O)=C1 SSPCELDPIFWFOR-YPCIICBESA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- FFRFJIZJLZXEJX-YPCIICBESA-N 1-(3,4-Dihydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(O)C(O)=CC=2)=C1 FFRFJIZJLZXEJX-YPCIICBESA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001398 aluminium Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 150000004783 arabinoxylans Chemical class 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 229920001688 coating polymer Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009484 foam granulation Methods 0.000 description 1
- 238000009483 freeze granulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002313 glycerolipids Chemical class 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- FETSQPAGYOVAQU-UHFFFAOYSA-N glyceryl palmitostearate Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O FETSQPAGYOVAQU-UHFFFAOYSA-N 0.000 description 1
- 229940046813 glyceryl palmitostearate Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000007909 melt granulation Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000223 polyglycerol Chemical class 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- ASUAYTHWZCLXAN-UHFFFAOYSA-N prenol Chemical compound CC(C)=CCO ASUAYTHWZCLXAN-UHFFFAOYSA-N 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009485 reverse wet granulation Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003313 saccharo lipids Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000009479 steam granulation Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Definitions
- the present invention relates to a non-colouring turmeric formulation and a process for the preparation thereof.
- the formulation may be specifically comprised of turmeric powder or a blend of turmeric powder and curcumin extract, combined in various ratios ranging from 50:1 to 5:1.
- the turmeric formulation may further be comprised of about 10% to 25% by weight of at least one non-polymeric encapsulating agent and at least one excipient, which is acceptable in nutraceutical, food, cosmetic and pharmaceutical industry.
- Turmeric formulation is granular, free flowing and exhibits non-colouring property, wherein it does not stain the surfaces in contact and also does not cause dusting and impart any coloration to the equipment or formulation area while converting the granules in desired dosage forms.
- the invention also relates to the process for preparation of non-colouring formulation, wherein the blend of turmeric powder and curcumin extract may be granulated using at least one excipient and the granules are encapsulated with at least one non-polymeric agent using suitable equipment.
- the process for preparation is simple, cost effective and environment friendly.
- the granular formulation retains characteristic bright colour of turmeric, however it does not leach out colour of the active, while converting into various solid and semisolid dosage forms, thus avoiding the need for frequent intermittent cleaning process and is industrially useful and convenient for subjecting to various formulation related operations,
- Turmeric (Curcuma longa) is used as a spice, preservative, colouring matter and has wide range of medicinal and pharmacological applications. It exhibits anti inflammatory, anti-HIV, anti-bacterial, antioxidant, nematocidal, antiparasitic, antispasmodic and anticarcinogenic activities. It is a potent scavenger of a variety of reactive oxygen species (ROS) including superoxide anion, hydroxyl radical, singlet oxygen, peroxynitrite and nitric oxide. It plays a active role in the inhibition of COX- I and COX-II enzymes that are involved in the inflammatory reaction. It prevents oxidative damage and inhibits binding of toxic metabolites to DNA.
- ROS reactive oxygen species
- Turmeric contains 3-6% polyphenolic compounds, collectively known as curcuminoids, which is a mixture of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids are major components responsible for various biological actions. However, some studies suggest that turmeric powder has significant health benefits, and it's possible that it has benefits that curcumin alone doesn't, but most possibly because of presence of fibres and essential oils as well.
- Turmeric powder as well as rhizome has been also used in food and Ayurvedic medicines since thousands of years for its medicinal properties in liver disorders, and wide variety of pulmonary, gastrointestinal and skin diseases. It keeps skin soft and smooth, makes it glow, tackles acne and helps treat hyper-pigmentation.
- Turmeric paste is also prescribed in Indian medicine for various skincare issues, like puffiness, wrinkles and eczema. Besides this, it is used for cuts and burns due to its antiseptic effect and ability to promote healing. In addition, it can help to decrease muscle soreness after an intense workout.
- US20180042858 describes a non-bleeding curcumin composition
- a non-bleeding curcumin composition comprising curcumin and a coating polymer wherein the polymer is selected from the group consisting of a biopolymer, synthetic polymer or a mixture thereof.
- the biopolymer is selected from the group consisting of cellulose, shellac, galactomannans, glucomannans, arabinoxylans, natural gums, proteins or a mixture thereof and the synthetic polymers is selected from the group consisting of polyvinyl alcohol, polylactic acids or a mixture thereof.
- the non-bleeding curcumin composition eliminate the problems of colour bleeding, colour leaching, colour staining and dusting during the industrial processing of curcumin.
- US8568802 describes composition with enriched fraction of tetrahydroxy curcumin and its tetrahydro analogs, comprising tetrahydroxy curcumin, demethyl curcumin, dimethyl monodemethoxy curcumin and bisdemethoxycurcumin.
- the said enriched fraction of tetra hydroxycurcumin is subjected to hydrogenation to get colourless tetrahydroxy curcumin enriched fraction.
- the enriched fractions of tetrahydroxy curcumin and colourless tetrahydro tetra hydroxycurcumin exhibits potent antioxidative action and reduces inflammation.
- US20170258743 describes process of preparation of white curcumin wherein the process comprises of treating curcuminoids with ethyl acetate to form a reaction mixture and adding palladium carbon as catalyst to the reaction mixture and allowed for hydrogenation in the presence of hydrogen gas.
- the reaction mixture is filtered and washed with ethyl acetate.
- the ethyl acetate is distilled to obtain a crude mass of white curcumin.
- Prior art references mainly focus on chemical modification of curcuminoids through demethylation or hydrogenation or physical masking of colour through polymeric coating of curcuminoids by using synthetic or natural excipients for overcoming the problem of colour staining and dusting during industrial processing of curcuminoids.
- curcuminoids may not be desired for application in nutraceutical, food and cosmetic industry.
- polymeric coating of curcuminoids for colour masking depends on percentage of coating excipient applied on the active and evenness of the coating. Slight rupture of coating during handling or processing may result into staining of the contact surfaces, formulation area and the equipment.
- turmeric powder can be used in blend with curcumin extract, to get entire spectrum of the benefits from all the constituents present in turmeric powder as well as the extract.
- the researchers of the present invention have carried out extensive experimentation using a blend of turmeric powder and curcumin extract, which was successfully converted into a non-colouring formulation of turmeric. It was surprisingly found that, with proper selection and optimization of encapsulating agents as well as process, the researchers could convert blend of turmeric powder and curcumin extract into coated granular and free flowing, which exhibits non-colouring property, wherein it does not cause any staining, colouring, or dusting while handling the granules for processing or converting into finished dosage form.
- Turmeric powder which is otherwise highly amorphous in nature and has very poor flow and characteristic staining properties, could be successfully converted into a formulation, which does not leach out even during compression process into tablet dosage form; while still retaining its characteristic colour.
- the granular formulation is prepared by using a combination of excipient and encapsulating agent, resulting into excellent flow and non-colouring property, which makes it suitable and convenient for converting into solid and semisolid dosage forms.
- the process employed by the researchers of the invention for encapsulation is carried out at controlled heat condition, wherein the molten non polymeric encapsulating agent is applied to fluidized granules using suitable equipment.
- the non-colouring turmeric formulation, as described herein is comprised of a blend of turmeric powder and curcumin extract in various ratios, ranging from 50:1 to 5:1, thus incorporating wide spectrum of constituents from both the counterparts in the granular form, which is very useful for applications in food, nutraceuticals, pharmaceutical as well as cosmetics industry.
- the main objective of the invention is to provide a non-colouring, free flowing and granular formulation comprising turmeric powder, which does not cause dusting or staining of the contact parts, equipment, or formulation area, while processing into final dosage form.
- Important objective of the invention is to provide a non-colouring formulation, comprising turmeric powder, which retains its characteristic colour; but does not leach it out even during the compression of granules into compressible dosage forms or conversion in other suitable solid and semisolid dosage forms.
- Another objective of the invention is to provide the turmeric formulation, wherein the blend of turmeric powder and curcumin extract may be used in various ratios ranging from 50: 1 to 5:1.
- One more objective of the invention is to provide a granular, non-colouring formulation comprising blend of turmeric powder with curcumin extract and at least about 10% to 25% by weight of non-polymeric encapsulating agent or a combination thereof.
- One objective of the invention is to provide a non-colouring turmeric formulation comprising turmeric powder, a non-polymeric encapsulating agent and at least one excipient, which is acceptable in nutraceutical, food, cosmetics and pharmaceutical industry.
- One important objective of the present invention is to provide a process for preparation, wherein blend of turmeric powder with curcumin extract may be granulated using at least one excipient and the granules may be encapsulated with a non-polymeric agent using suitable equipment.
- One objective of the invention is to provide a non-colouring granular formulation of turmeric, wherein the granule size may range from 100 microns to 900 microns.
- One important objective of the formulation is to provide a turmeric formulation, which can be converted into various solid and semisolid dosage forms without staining, dusting or colouring the contacting body parts, surfaces, working area and equipment.
- Figure 1 demonstrates the evaluation of non-colouring property of the turmeric formulation, wherein the granular formulation is compressed into tablet dosage form, and it does not colour any of the compression equipment, even after carrying out the compression process for about 4 hours.
- Figure 2 demonstrates structural elucidation of encapsulated granules, which is carried out using scanning electron microscopy of cross-section surfaces of granules. It indicates uniform coating of granules by non-polymeric encapsulating agent, which is confirmed through measurement of coating thickness in microns.
- the invention relates to a non-colouring turmeric formulation, which is comprised of a blend of turmeric powder with curcumin extract in various ratios, ranging from 50: 1 to 5:1.
- the formulation is also comprised of about 10% to 25% by weight of a non- polymeric encapsulating agent and at least one excipient which is acceptable in food, nutraceutical, cosmetic and pharmaceutical industry.
- Turmeric formulation, as described herein, may be comprised of about 2% to 20% of total curcuminoids.
- the invention also relates to a process for preparation of turmeric formulation, wherein turmeric powder or its the blend with curcumin extract is granulated using at least one excipient and the resulting granules are treated with a non-polymeric encapsulating agent to get a non-colouring, free flowing formulation, thus, incorporating wide spectrum of constituents from both the counterparts in the granular form, which is very useful for applications in food, nutraceuticals as well as cosmetic industry.
- the present invention employs blend of turmeric powder with curcumin extract, both of which are derived from Curcuma species of the Zingiberaceae (ginger) family.
- turmeric powder as used herein means the powder obtained from roots, tubers or rhizomes of the Curcuma species of the Zingiberaceae (ginger) family including but not limited to species like Curcuma longa, Curcuma amada, Curcuma angustifolra, Curcuma caesia, Curcuma zedoaria, Curcuma caulina, Curcuma aromatica, Curcuma wenyujin, Curcuma xanfhorrhiza, Curcuma phaeocaulis, Curcuma leucorrhiza and Curcuma kwangsiensis.
- turmeric powder It is light yellow to yellowish orange in colour and also has characteristic odour and taste.
- Seasonal and geographical variation may bring some changes to the colour shade of turmeric powder in the range of light yellow, yellow, orangish yellow to yellowish orange, although the basic shade remains common in general, which is very characteristic to curcuma species.
- It contains at least about 2% of the curcuminoids along with essential oil, fibers and other natural components.
- Turmeric powder is very fine in size, amorphous in nature and exhibits poor flow. It tends to generate lots of dusting and results in staining of the processing area, equipment and contact surfaces due to its fine particle size and characteristic colour. Complete cleaning and changeover of the area, clothes and equipment is therefore required after processing any turmeric product, resulting into wastage of time, money and use of costly organic solvents.
- the present invention provides a granular, free flowing and non-coloring formulation of turmeric powder which overcomes all processing difficulties of turmeric powder and provides an ingredient formulation, which can be conveniently converted in required solid and semisolid dosage forms like tablets, caplets, capsules, stick packs, creams, ointments and other suitable dosage forms as per the requirement.
- curcumin extract is used herein to mean the extract of roots, tubers or rhizomes of the Curcuma species of the Zingiberaceae (ginger) family including but not limited to species like Curcuma longa, Curcuma amada, Curcuma angustifolra, Curcuma caesia, Curcuma zedoaria, Curcuma caulina, Curcuma aromatica, Curcuma wenyujin, Curcuma xanfliorrhiza, Curcuma phaeocaulis, Curcuma leucorrhiza and Curcuma kwangsiensis.
- Curcumin extract is comprised of curcumin (diferuloylmethane), desmethoxycurcumin, or bisdesmethoxycurcumin, including their polymorphs, hydrates, solvates, derivatives, and mixtures thereof.
- Curcumin extract is a yellowish orange coloured fine powder with characteristic odour and taste, although geographical and seasonal variations may bring change in colour shades. It is comprised of at least about 95% w/w of curcuminoids, calculated in the form of curcumin, desmethoxycurcumin and bisdemethoxycurcumin, including their polymorphs, hydrates, solvates, derivatives, and mixtures thereof.
- the terminology ‘blend’ as used herein means the uniform mixture of two active components employed in the non-coloring formulation.
- the blend is comprised of turmeric powder and curcumin extract.
- the non-coloring formulation as described herein may be comprised of blend of turmeric powder and curcumin extract in various ratios ranging from 50:1 to 5:1. More preferably, the formulation may be comprised of blend of turmeric powder and curcumin extract in ratio ranging from 45: 1 to 6:1, as per the requirement.
- the formulation may also be comprised of turmeric powder alone, which is converted in the form of granules by using the process, as described herein.
- the formulation may be comprised of about 2% to 20% of total curcuminoids, as obtained from turmeric powder alone or the blend of turmeric powder and curcumin extract.
- the formulation may preferably be comprised of about 5 to 15% by weight of total curcuminoids in granular form.
- non-coloring means property of the granular formulation of turmeric powder, as described herein, by virtue of which, it does not confer its yellow to yellowish orange colour, which is characteristic of unformulated turmeric powder, to any of the contact surfaces or equipment, while processing into finished dosage forms.
- these equipment do not get stained and also the formulation area does not get dusted due to turmeric powder in granular composition.
- the composition is prepared from the blend of turmeric powder and curcumin extract, which have very peculiar and characteristic yellow to yellowish orange colour, the formulation exhibits non coloring characteristic, in its granular form.
- yellow to yellowish orange refers to colour range of turmeric powder and curcumin extract, wherein the colour may vary from different shades of yellow to red to orange.
- the shade of turmeric powder as well as curcumin extract may vary depending upon source, processing conditions, storage conditions, but the spectrum of colour shade may vary from bright yellow, light yellow to light orange or reddish orange or dark yellowish orange.
- the granular non-coloring formulation as described herein retains the colour shade of unformulated turmeric powder or blend of turmeric powder and curcumin extract; but does not stain or color the contact surfaces, while processing into final dosage forms.
- non-polymeric encapsulating agent refers to the agent or excipient employed in the non-coloring formulation, for covering the granules comprising turmeric powder or its blend with curcumin extract. It covers and or encapsulates the granules, to confer the non-coloring property. It also acts as a seal coating and provides the protection to core granules from ingress of moisture and other gases.
- the formulation as described herein may be comprised of at least about 10-25% by weight of non-polymeric encapsulating agent.
- Non-polymeric encapsulating agent may be selected from the group of lipids, fats, fatty acids, fatty alcohols, fatty acid esters, waxes, and the combination thereof.
- Fats which are used for the embodiments of the present invention, consist of a wide group of compounds that are generally soluble in organic solvents and largely insoluble in water.
- Hydrogenated fats (or saturated fats) in the context of the present invention are generally triesters of glycerol and fatty acids. Fatty acids are chains of carbon and hydrogen atoms, with a carboxylic acid group at one end. Such fats can have natural or synthetic origin. It is possible to hydrogenate a (poly)unsaturated fat to obtain a hydrogenated (saturated) fat.
- the non-polymeric encapsulating agent may be selected from, but not limited to, saturated fatty acids having 12 to 28 carbons, such as stearic acid, palmitic acid, fatty alcohols having from 16 to 44 carbons, cetyl alcohol, soya fat, pegylated fatty acids, glycerol fatty acid esters, derivatives of mono-diglycerides, glyceryl behenate, glyceryl monostearate, glyceryl palmitostearate, phosphatides, cerebrosides, gangliosides, cephalins, lipids, glycolipids, sulfatides, sugar esters, sugar ethers, sucrose esters, sterols, polyglycerol esters, glycerolipid, phosphatic acid, phosphatidylethanolamine, phosphatidylserine, or other glycerophospholipids, ceramide, sphingolipid, sterol, fat-soluble vitamin
- Waxes in the context of the present invention are organic compounds that characteristically consist of long alkyl chains. Natural waxes (plant, animal) are typically esters of fatty acids and long chain alcohols. Synthetic waxes are long- chain hydrocarbons lacking functional groups.
- the encapsulating agent, as described herein may also be selected from, but not limited to, beeswax, candelilla wax, carnauba wax, spermaceti, paraffin wax, synthetic waxes and the combination thereof.
- fats suitable for the present invention are glycerine monostearate, stearic acid, hydrogenated cottonseed fat, hydrogenated palm fat and hydrogenated rapeseed fat, hydrogenated palm fat, hydrogenated soyabean fat, hydrogenated sunflower fat, hydrogenated rapeseed fat, soya fat, palmitic acid. These compounds can be used as such or as mixtures.
- non-colouring formulation may be comprised of 1% to 20% by weight of excipients, which are acceptable in food, nutraceutical, cosmetics and pharmaceutical industry.
- Excipients may facilitate the granulation of turmeric powder or its blend with curcumin extract.
- the excipient may also facilitate conversion of granule formulation in desired dosage form, suitable for administration.
- ingredients in industry are selected from the group of, but not limited to, fillers, diluents, disintegrants, lubricants, binders, glidants, anti caking agents, stabilizers, surfactants, channelizing agents, vehicles, buffers, stabilizers, preservatives, acidifiers, alkalizers, complexing agents, gum bases, antioxidants, viscosity enhancers, plasticizers, coating materials, and the combination thereof.
- the excipients may belong to the class such as polymeric, non-polymeric, swelling, non-swelling, pH dependent and pH independent additives.
- the non-colouring turmeric formulation, as described herein, may be comprised of about 1 to 20% by weight of additives, which are selected from natural, semi-synthetic or synthetic sources. More preferably, the formulation may be comprised of about 1 to 15% by weight of excipients.
- the formulation may be comprised of diluents known in the art, but not limited to microcrystalline cellulose, silicified microcrystalline, cellulose, powdered cellulose, microfine cellulose, corn starch, rice bran extract, calcium phosphate, dibasic calcium phosphate, tribasic calcium phosphate, calcium sulfate, or mixtures thereof.
- the diluents may also be selected from glucose, lactose, sucrose, dextrose, fructose, compressible sugar, or mixtures thereof.
- the binders may be selected from the group of cellulose derivatives such as hydroxypropylmethyl cellulose (HPMC), hydroxypropyl cellulose (HPC), ethylcellulose, carboxymethylcellulose (CMC), sodium CMC, potassium CMC, calcium CMC, methylcellulose, hydroxyethyl cellulose (HEC), microcrystalline cellulose; polyvinylpyrrolidone (PVP), vinyl pyrrolidone-vinyl acetate copolymer, polyvinyl alcohol, starch, carbomer, gums like xanthan gum, guar gum, acacia, locust bean gum, alginates, or mixtures thereof.
- HPMC hydroxypropylmethyl cellulose
- HPC hydroxypropyl cellulose
- CMC carboxymethylcellulose
- HEC hydroxyethyl cellulose
- PVP polyvinylpyrrolidone
- PVP vinyl pyrrolidone-vinyl acetate copolymer
- polyvinyl alcohol starch
- the disintegrants may be selected from sodium starch glycolate, crospovidone, croscarmellose sodium, croscarmellose calcium, croscarmellose potassium, sodium carbonate, sodium hydrogen carbonate, calcium carbonate, starch, starch 1500, modified starch, pregelatinized starch, crosslinked carboxymethyl starch, sodium hydrogen carbonate, hydroxypropyl cellulose, sodium carboxymethylcellulose or mixtures thereof.
- the formulation may be prepared by using blend of turmeric powder and curcumin extract, which can be prepared by mixing both the powder components well using a suitable blender and/or mixer.
- Turmeric powder may be mixed with curcumin extract in different ratios, ranging from 50:1 to 5:1, to give rise to different variants of the non-colouring turmeric formulation.
- turmeric powder or its blend with curcumin extract can be granulated using at least one excipient, employing various granulation processes known in the art such as dry granulation, wet granulation, melt granulation, extrusion spheronization, coacervation, congealing, reverse wet granulation, steam granulation, freeze granulation, foam granulation and the like.
- the granules may be prepared by single step or multi-step granulation, using various suitable granulation equipment such as rapid mixer granulator, liquid mixer granulator, oscillating granulator, ribbon mixer granulator, extrusion spheronizer, hot melt extruder, roller compactor, fluid bed granulator, which are generally used in food, nutraceutical, cosmetics or pharmaceutical industry.
- suitable granulation equipment such as rapid mixer granulator, liquid mixer granulator, oscillating granulator, ribbon mixer granulator, extrusion spheronizer, hot melt extruder, roller compactor, fluid bed granulator, which are generally used in food, nutraceutical, cosmetics or pharmaceutical industry.
- the formulation may be prepared by wet granulation process using a binder and the agglomerates can be dried and sieved through suitable sieve to get the granules of desired size.
- the granules may be treated with a non-polymeric encapsulating agent using controlled process conditions employing suitable coating equipment such as tangential fluid bed dryer, fluidized bed processor, bottom spray fluid bed drier or top spray fluid bed drier, rotary plate drier with circular, elliptical and fish gill like holes, or employing blenders like ribbon blender or using pan coaters to get a non-colouring turmeric formulation.
- the formulation may be prepared by using a combination of at least one excipient and a non-polymeric encapsulating agent, wherein the excipient such as binder or diluent is used to convert the blend into agglomerates, which are converted in granules.
- the granules may be treated with non-polymeric fatty encapsulating agent using controlled conditions of heat, wherein the encapsulating agent is applied to fluidized granules in the form of fine droplets under the current of air, using suitable equipment.
- the encapsulating agent may be applied on granules in multiple unform layers to offer non-colouring property.
- the formulation of the invention was evaluated for flow property, assay content, stability, non-colouring property, and microbial content.
- the formulation was also subjected to Scanning Electron Microscopy (SEM) characterization for structure elucidation of encapsulated granules, in order to check uniformity of coating on the granules.
- the non-colouring turmeric granules as described herein are prepared by using non- polymeric encapsulating agent, which acts as an effective seal coating agent.
- the coating may also offer very good protection from microbial load as the microbes can’t survive in fat medium at the temperature employed for the purpose of coating or encapsulation.
- the surface of granules may get stabilized during the process of encapsulation, resulting in considerable reduction in the microbial load, which might have got introduced from turmeric powder.
- Granular formulation prepared by the process as described herein retains the characteristic yellowish orange colour the active even after the granulation, but it exhibits non-colouring and non-dusting property. As per this property, the granules avoid staining and dusting of yellowish orange colour, while processing it in finished dosage form.
- the granular non-colouring formulation of turmeric powder as described herein exhibits excellent flow property and it may overcome process difficulties such as bulk handling of turmeric powder and/or curcumin extract, and overcomes the problem of colour explosion and dusting characteristics, which may make the formulation production troublesome, expensive and time consuming because of complete change over cleaning required using organic solvents after manufacturing the batches.
- composition as described herein is prepared by using environment friendly solvent for granulation and a non-polymeric encapsulating agent.
- the granules prepared by this process overcome the tedious problems of staining of the equipment and other contact surfaces and therefore are useful for formulation into finished dosage forms.
- the granular formulation as described herein, can be used as directly compressible grade granules, which can be compressed in tablets, without adding any other excipient like diluent, filler or binder and the combination thereof. This property adds to the industrial usefulness of the formulation, for converting the granules in tablet dosage forms, by retaining the percentage of active constituent, without diluting if further by addition of any excipients for compression purpose.
- the non-colouring granular formulation as described herein has various advantages with respect to industrial processing.
- the formulation is comprised of turmeric powder or the blend of turmeric powder and curcumin extract, which combines whole spectrum of active constituents present in turmeric powder and the curcumin extract, such as curcuminoids, turmeric oil, and fibres, thus offering additional benefits to the consumers.
- Turmeric oil may offer advantage with respect to enhanced solubility and absorption of the formulation in the body system.
- Non-colouring formulation of the invention can be converted into tablets, capsules and other dosage forms by using suitable excipients, processes and equipment employed in nutraceutical, pharmaceutical or food industry. The granules do not stain the equipment used in the processing, thus making the formulation process convenient and industrially useful.
- Example 1 Non-colouring formulation comprising Turmeric powder: Curcumin extract (15:1)
- Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend.
- the binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size.
- the turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 30-55° C to get light to dark yellowish orange colour product, which is free flowing and exhibits non-colouring property.
- the non-colouring property of turmeric granules obtained by the process disclosed in example 1 was evaluated during the compression in tablet dosage form.
- the formulation, which was obtained in the form of directly compressible grade (DC grade) granules was subjected to the process of continuous tabletting for about 4 hours in a single rotary, 16 station tablet compression machine using a caplet size punch, which is oval, standard concave and plain on both sides.
- IPQC in-process quality check
- Example 3 Stability study of granules of Example 1
- Example 1 Free flowing granules of Example 1 were subjected to accelerated stability study in a tri-laminated aluminium pouch and the assay evaluation was carried out using HPLC analysis to understand the content of active over 6 months at standard condition of temperature and humidity. The granules were also evaluated for microbial load during stability study and the results of evaluation are tabulated in Table 3.
- Example 4 Non-colouring formulation comprising turmeric powder:
- Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend.
- the binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size.
- the turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C. The granules are compressed in tablets for evaluation of curcuminoid contents.
- curcuminoid content of the non-colouring turmeric granules of example 4 were evaluated by HPLC evaluation using a tetrahydrofuran : citric acid anhydrous buffer mobile phase.
- the solution of working standard and test sample were prepared in methanol and injected in the system for determining the content of total curcuminoids, curcumin, desmethoxy curcumin and bisdesmethoxy curcumin.
- the turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend.
- the binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size.
- the turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C.
- Example 6 Non-colouring formulation comprising turmeric powder: curcumin extract (5:1)
- Table 7 Composition of non-colouring turmeric formulation Process for preparation:
- Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend.
- the binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size.
- the turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C.
- the turmeric granules are coated with molten hydrogenated palm fat solids using hot melt technique.
- the encapsulation may be carried out under the current of air by spraying fine droplets molten fat in a fluidized bed processor.
- Table 8 The wall thickness of the turmeric granules measured through electron microscope
- Example 8 Evaluation of non-colouring property of turmeric granules
- the non-colouring property of the formulation was evaluated by comparative study wherein, effect of both the granular formulation and unformulated turmeric blend (turmeric powder and curcumin extract mixture in the same ratio as used in the formulated non-colouring product) on contact surface and the difference in the extent of cleaning required during processing of both the product was checked using equipment plate, followed by visual observation and UV absorbance of rinse solution at 420nm.
- turmeric blend turmeric powder and curcumin extract mixture in the same ratio as used in the formulated non-colouring product
- Non-colouring turmeric granular formulation was spread evenly on a steel plate and the product was removed on the butter paper.
- the plate was rinsed with methanol and the rinsate was analysed using UV absorbance at 420 nm.
- the same procedure was repeated for unformulated turmeric blend formulation and the number of rinsates were analyzed using UV spectrophotometer.
- formulated turmeric blend granules are 116 times less staining than unformulated turmeric blend powder.
- the formulation, as described herein needs maximum 2 times rinsing to clear off the contact surface, in comparison to 4 rinsing required for unformulated turmeric blend, in order to get zero reading for total curcuminoids on UV Spectrophotometer at 420 nm.
- the non-colouring formulation requires less number of washings to clean the contact surfaces or the equipment, as compared to the unformulated turmeric blend powder, which required multiple cleaning cycles, in order to clean the contact surface and equipment, before switching over to another product in the processing area.
- Non-colouring turmeric formulation, as described herein is thus convenient to process, involves less time and cost for cleaning the equipment and switching over to another product. It does not stain the contact surfaces and avoids dusting in the formulation area, thus proves to be industrially useful.
- the formulation is free flowing and can be conveniently converted in suitable compressible and other dosage forms, as per requirement.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a non-colouring turmeric formulation comprised of a blend of turmeric powder and curcumin extract, combined with at least about 10 to 25% by weight of a non-polymeric encapsulating agent and at least one excipient. The formulation may be comprised of blend of turmeric powder and curcumin extract, combined in various ratios ranging from 50:1 to 5:1. The invention also relates to the process for preparation of non-colouring formulation, wherein turmeric powder or its blend with curcumin extract may be granulated using at least one excipient and the granules are encapsulated using non-polymeric agent. The process for preparation is simple, cost effective and environment friendly. The non-colouring formulation is granular, free flowing and retains characteristic colour of the active; but does not cause any dusting and coloration of the area, contact surfaces and the equipment, while converting into various dosage forms.
Description
Non-colouring turmeric formulation and a process for preparation thereof Field of The Invention
The present invention relates to a non-colouring turmeric formulation and a process for the preparation thereof. The formulation may be specifically comprised of turmeric powder or a blend of turmeric powder and curcumin extract, combined in various ratios ranging from 50:1 to 5:1. The turmeric formulation may further be comprised of about 10% to 25% by weight of at least one non-polymeric encapsulating agent and at least one excipient, which is acceptable in nutraceutical, food, cosmetic and pharmaceutical industry. Turmeric formulation is granular, free flowing and exhibits non-colouring property, wherein it does not stain the surfaces in contact and also does not cause dusting and impart any coloration to the equipment or formulation area while converting the granules in desired dosage forms. The invention also relates to the process for preparation of non-colouring formulation, wherein the blend of turmeric powder and curcumin extract may be granulated using at least one excipient and the granules are encapsulated with at least one non-polymeric agent using suitable equipment. The process for preparation is simple, cost effective and environment friendly. The granular formulation retains characteristic bright colour of turmeric, however it does not leach out colour of the active, while converting into various solid and semisolid dosage forms, thus avoiding the need for frequent intermittent cleaning process and is industrially useful and convenient for subjecting to various formulation related operations,
Background
Turmeric (Curcuma longa) is used as a spice, preservative, colouring matter and has wide range of medicinal and pharmacological applications. It exhibits anti inflammatory, anti-HIV, anti-bacterial, antioxidant, nematocidal, antiparasitic, antispasmodic and anticarcinogenic activities. It is a potent scavenger of a variety of reactive oxygen species (ROS) including superoxide anion, hydroxyl radical, singlet oxygen, peroxynitrite and nitric oxide. It plays a active role in the inhibition of COX- I and COX-II enzymes that are involved in the inflammatory reaction. It prevents oxidative damage and inhibits binding of toxic metabolites to DNA. Turmeric
contains 3-6% polyphenolic compounds, collectively known as curcuminoids, which is a mixture of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids are major components responsible for various biological actions. However, some studies suggest that turmeric powder has significant health benefits, and it's possible that it has benefits that curcumin alone doesn't, but most possibly because of presence of fibres and essential oils as well.
In Asian countries, fresh and dry turmeric rhizomes as well as ground turmeric is used for vegetable and meat dishes and soup-like products. Turmeric powder as well as rhizome has been also used in food and Ayurvedic medicines since thousands of years for its medicinal properties in liver disorders, and wide variety of pulmonary, gastrointestinal and skin diseases. It keeps skin soft and smooth, makes it glow, tackles acne and helps treat hyper-pigmentation. Turmeric paste is also prescribed in Indian medicine for various skincare issues, like puffiness, wrinkles and eczema. Besides this, it is used for cuts and burns due to its antiseptic effect and ability to promote healing. In addition, it can help to decrease muscle soreness after an intense workout.
Even though there has been an increasing interest in turmeric due to its medicinal properties over the past few years, handling or processing of this product in regular powder form is a big problem due to its amorphous nature, poor flow properties, along with staining and dusting properties. Turmeric powder as well as curcumin extract stain the equipment and contact surfaces, while handling it or formulating in dosage forms, and therefore make the production process troublesome and time consuming. Turmeric powder as well as curcuminoids also cause dusting in the formulation area and therefore the entire plant needs complete change over cleaning, which is very often done using organic solvents, thus involves considerable cost, time and therefore affecting the production efficiency.
Prior art patent applications in this subject area are mainly focused on either use of hydrophilic natural polymers or use of various catalytic or other hydrogenation reactions to get non- staining curcuminoid formulations.
IN201402079 describes a process for preparation of glycosylated tetrahydrocurcumin, which is a major colourless metabolite of curcuminoids isolated from Curcuma longa. The process was comprised of glycosylation process and use of a phase transfer catalyst. Tetrahydrocurcumin-di-P-glycoside was synthesized, and its biological and pharmacological activity was evaluated. The accelerated wound-healing process with non-toxic, non-irritant and non-staining properties render this multi-functional compound tetrahydrocurcumin-di-P-glucoside as a useful ingredient in achromatic food and cosmetic applications.
US20180042858 describes a non-bleeding curcumin composition comprising curcumin and a coating polymer wherein the polymer is selected from the group consisting of a biopolymer, synthetic polymer or a mixture thereof. The biopolymer is selected from the group consisting of cellulose, shellac, galactomannans, glucomannans, arabinoxylans, natural gums, proteins or a mixture thereof and the synthetic polymers is selected from the group consisting of polyvinyl alcohol, polylactic acids or a mixture thereof. The non-bleeding curcumin composition eliminate the problems of colour bleeding, colour leaching, colour staining and dusting during the industrial processing of curcumin.
US8568802 describes composition with enriched fraction of tetrahydroxy curcumin and its tetrahydro analogs, comprising tetrahydroxy curcumin, demethyl curcumin, dimethyl monodemethoxy curcumin and bisdemethoxycurcumin. The said enriched fraction of tetra hydroxycurcumin is subjected to hydrogenation to get colourless tetrahydroxy curcumin enriched fraction. The enriched fractions of tetrahydroxy curcumin and colourless tetrahydro tetra hydroxycurcumin exhibits potent antioxidative action and reduces inflammation.
US20170258743 describes process of preparation of white curcumin wherein the process comprises of treating curcuminoids with ethyl acetate to form a reaction mixture and adding palladium carbon as catalyst to the reaction mixture and allowed for hydrogenation in the presence of hydrogen gas. the reaction mixture is filtered and washed with ethyl acetate. The ethyl acetate is distilled to obtain a crude mass of white curcumin.
Prior art references mainly focus on chemical modification of curcuminoids through demethylation or hydrogenation or physical masking of colour through polymeric coating of curcuminoids by using synthetic or natural excipients for overcoming the problem of colour staining and dusting during industrial processing of curcuminoids. However, this may result into chemical transformation of curcuminoids along with change in its natural bright yellowish orange colour, which may not be desired for application in nutraceutical, food and cosmetic industry. Further the polymeric coating of curcuminoids for colour masking depends on percentage of coating excipient applied on the active and evenness of the coating. Slight rupture of coating during handling or processing may result into staining of the contact surfaces, formulation area and the equipment.
Summary
There is an unmet need to find out alternate ways to overcome the staining property of turmeric, without disturbing or disrupting its chemical identity, physical characteristics as well as original colour, thus making the product acceptable and suitable for foods, cosmetic and nutraceuticals applications. Moreover, it would be preferable, if turmeric powder can be used in blend with curcumin extract, to get entire spectrum of the benefits from all the constituents present in turmeric powder as well as the extract.
The researchers of the present invention have carried out extensive experimentation using a blend of turmeric powder and curcumin extract, which was successfully converted into a non-colouring formulation of turmeric. It was surprisingly found that, with proper selection and optimization of encapsulating agents as well as process, the researchers could convert blend of turmeric powder and curcumin extract into coated granular and free flowing, which exhibits non-colouring property, wherein it does not cause any staining, colouring, or dusting while handling the granules for processing or converting into finished dosage form. Turmeric powder, which is otherwise highly amorphous in nature and has very poor flow and characteristic staining properties, could be successfully converted into a formulation, which does not leach out even during compression process into tablet dosage form; while still retaining its
characteristic colour. The granular formulation is prepared by using a combination of excipient and encapsulating agent, resulting into excellent flow and non-colouring property, which makes it suitable and convenient for converting into solid and semisolid dosage forms. The process employed by the researchers of the invention for encapsulation is carried out at controlled heat condition, wherein the molten non polymeric encapsulating agent is applied to fluidized granules using suitable equipment. The non-colouring turmeric formulation, as described herein is comprised of a blend of turmeric powder and curcumin extract in various ratios, ranging from 50:1 to 5:1, thus incorporating wide spectrum of constituents from both the counterparts in the granular form, which is very useful for applications in food, nutraceuticals, pharmaceutical as well as cosmetics industry.
None of the prior art references describe a blend formulation of turmeric powder and curcumin extract, as described herein, which possesses excellent flow and exhibits non-colouring property, while retaining characteristic colour of turmeric.
Objectives
The main objective of the invention is to provide a non-colouring, free flowing and granular formulation comprising turmeric powder, which does not cause dusting or staining of the contact parts, equipment, or formulation area, while processing into final dosage form.
Important objective of the invention is to provide a non-colouring formulation, comprising turmeric powder, which retains its characteristic colour; but does not leach it out even during the compression of granules into compressible dosage forms or conversion in other suitable solid and semisolid dosage forms.
Another objective of the invention is to provide the turmeric formulation, wherein the blend of turmeric powder and curcumin extract may be used in various ratios ranging from 50: 1 to 5:1.
One more objective of the invention is to provide a granular, non-colouring formulation comprising blend of turmeric powder with curcumin extract and at least
about 10% to 25% by weight of non-polymeric encapsulating agent or a combination thereof.
One objective of the invention is to provide a non-colouring turmeric formulation comprising turmeric powder, a non-polymeric encapsulating agent and at least one excipient, which is acceptable in nutraceutical, food, cosmetics and pharmaceutical industry.
One important objective of the present invention is to provide a process for preparation, wherein blend of turmeric powder with curcumin extract may be granulated using at least one excipient and the granules may be encapsulated with a non-polymeric agent using suitable equipment.
One objective of the invention is to provide a non-colouring granular formulation of turmeric, wherein the granule size may range from 100 microns to 900 microns.
One important objective of the formulation is to provide a turmeric formulation, which can be converted into various solid and semisolid dosage forms without staining, dusting or colouring the contacting body parts, surfaces, working area and equipment.
Description of the Figure
Figure 1 demonstrates the evaluation of non-colouring property of the turmeric formulation, wherein the granular formulation is compressed into tablet dosage form, and it does not colour any of the compression equipment, even after carrying out the compression process for about 4 hours.
Figure 2 demonstrates structural elucidation of encapsulated granules, which is carried out using scanning electron microscopy of cross-section surfaces of granules. It indicates uniform coating of granules by non-polymeric encapsulating agent, which is confirmed through measurement of coating thickness in microns.
Detailed Description
The invention relates to a non-colouring turmeric formulation, which is comprised of a blend of turmeric powder with curcumin extract in various ratios, ranging from 50: 1 to 5:1. The formulation is also comprised of about 10% to 25% by weight of a non-
polymeric encapsulating agent and at least one excipient which is acceptable in food, nutraceutical, cosmetic and pharmaceutical industry. Turmeric formulation, as described herein, may be comprised of about 2% to 20% of total curcuminoids. The invention also relates to a process for preparation of turmeric formulation, wherein turmeric powder or its the blend with curcumin extract is granulated using at least one excipient and the resulting granules are treated with a non-polymeric encapsulating agent to get a non-colouring, free flowing formulation, thus, incorporating wide spectrum of constituents from both the counterparts in the granular form, which is very useful for applications in food, nutraceuticals as well as cosmetic industry.
The present invention employs blend of turmeric powder with curcumin extract, both of which are derived from Curcuma species of the Zingiberaceae (ginger) family.
The term ‘turmeric powder’ as used herein means the powder obtained from roots, tubers or rhizomes of the Curcuma species of the Zingiberaceae (ginger) family including but not limited to species like Curcuma longa, Curcuma amada, Curcuma angustifolra, Curcuma caesia, Curcuma zedoaria, Curcuma caulina, Curcuma aromatica, Curcuma wenyujin, Curcuma xanfhorrhiza, Curcuma phaeocaulis, Curcuma leucorrhiza and Curcuma kwangsiensis.
It is light yellow to yellowish orange in colour and also has characteristic odour and taste. Seasonal and geographical variation may bring some changes to the colour shade of turmeric powder in the range of light yellow, yellow, orangish yellow to yellowish orange, although the basic shade remains common in general, which is very characteristic to curcuma species. It contains at least about 2% of the curcuminoids along with essential oil, fibers and other natural components. Turmeric powder is very fine in size, amorphous in nature and exhibits poor flow. It tends to generate lots of dusting and results in staining of the processing area, equipment and contact surfaces due to its fine particle size and characteristic colour. Complete cleaning and changeover of the area, clothes and equipment is therefore required after processing any turmeric product, resulting into wastage of time, money and use of costly organic solvents.
The present invention provides a granular, free flowing and non-coloring formulation of turmeric powder which overcomes all processing difficulties of turmeric powder and provides an ingredient formulation, which can be conveniently converted in required solid and semisolid dosage forms like tablets, caplets, capsules, stick packs, creams, ointments and other suitable dosage forms as per the requirement.
The term ‘curcumin extract’ is used herein to mean the extract of roots, tubers or rhizomes of the Curcuma species of the Zingiberaceae (ginger) family including but not limited to species like Curcuma longa, Curcuma amada, Curcuma angustifolra, Curcuma caesia, Curcuma zedoaria, Curcuma caulina, Curcuma aromatica, Curcuma wenyujin, Curcuma xanfliorrhiza, Curcuma phaeocaulis, Curcuma leucorrhiza and Curcuma kwangsiensis.
Curcumin extract is comprised of curcumin (diferuloylmethane), desmethoxycurcumin, or bisdesmethoxycurcumin, including their polymorphs, hydrates, solvates, derivatives, and mixtures thereof. Curcumin extract is a yellowish orange coloured fine powder with characteristic odour and taste, although geographical and seasonal variations may bring change in colour shades. It is comprised of at least about 95% w/w of curcuminoids, calculated in the form of curcumin, desmethoxycurcumin and bisdemethoxycurcumin, including their polymorphs, hydrates, solvates, derivatives, and mixtures thereof.
The terminology ‘blend’ as used herein means the uniform mixture of two active components employed in the non-coloring formulation. The blend is comprised of turmeric powder and curcumin extract. The non-coloring formulation as described herein, may be comprised of blend of turmeric powder and curcumin extract in various ratios ranging from 50:1 to 5:1. More preferably, the formulation may be comprised of blend of turmeric powder and curcumin extract in ratio ranging from 45: 1 to 6:1, as per the requirement. The formulation may also be comprised of turmeric powder alone, which is converted in the form of granules by using the process, as described herein.
The formulation may be comprised of about 2% to 20% of total curcuminoids, as obtained from turmeric powder alone or the blend of turmeric powder and curcumin extract. The formulation may preferably be comprised of about 5 to 15% by weight of total curcuminoids in granular form.
The terminology ‘non-coloring’ as used herein means property of the granular formulation of turmeric powder, as described herein, by virtue of which, it does not confer its yellow to yellowish orange colour, which is characteristic of unformulated turmeric powder, to any of the contact surfaces or equipment, while processing into finished dosage forms. Thus even if the granules come in contact with equipment while carrying out processes like weighing, mixing, blending, filling and so on, these equipment do not get stained and also the formulation area does not get dusted due to turmeric powder in granular composition. Even though the composition is prepared from the blend of turmeric powder and curcumin extract, which have very peculiar and characteristic yellow to yellowish orange colour, the formulation exhibits non coloring characteristic, in its granular form.
The terminology ‘yellow to yellowish orange’ as used herein refers to colour range of turmeric powder and curcumin extract, wherein the colour may vary from different shades of yellow to red to orange. The shade of turmeric powder as well as curcumin extract may vary depending upon source, processing conditions, storage conditions, but the spectrum of colour shade may vary from bright yellow, light yellow to light orange or reddish orange or dark yellowish orange. The granular non-coloring formulation as described herein retains the colour shade of unformulated turmeric powder or blend of turmeric powder and curcumin extract; but does not stain or color the contact surfaces, while processing into final dosage forms.
The terminology ‘non-polymeric encapsulating agent’ as used herein refers to the agent or excipient employed in the non-coloring formulation, for covering the granules comprising turmeric powder or its blend with curcumin extract. It covers and or encapsulates the granules, to confer the non-coloring property. It also acts as a seal coating and provides the protection to core granules from ingress of moisture and
other gases. The formulation as described herein, may be comprised of at least about 10-25% by weight of non-polymeric encapsulating agent.
Non-polymeric encapsulating agent may be selected from the group of lipids, fats, fatty acids, fatty alcohols, fatty acid esters, waxes, and the combination thereof.
Fats, which are used for the embodiments of the present invention, consist of a wide group of compounds that are generally soluble in organic solvents and largely insoluble in water. Hydrogenated fats (or saturated fats) in the context of the present invention are generally triesters of glycerol and fatty acids. Fatty acids are chains of carbon and hydrogen atoms, with a carboxylic acid group at one end. Such fats can have natural or synthetic origin. It is possible to hydrogenate a (poly)unsaturated fat to obtain a hydrogenated (saturated) fat.
As per one more embodiment, the non-polymeric encapsulating agent may be selected from, but not limited to, saturated fatty acids having 12 to 28 carbons, such as stearic acid, palmitic acid, fatty alcohols having from 16 to 44 carbons, cetyl alcohol, soya fat, pegylated fatty acids, glycerol fatty acid esters, derivatives of mono-diglycerides, glyceryl behenate, glyceryl monostearate, glyceryl palmitostearate, phosphatides, cerebrosides, gangliosides, cephalins, lipids, glycolipids, sulfatides, sugar esters, sugar ethers, sucrose esters, sterols, polyglycerol esters, glycerolipid, phosphatic acid, phosphatidylethanolamine, phosphatidylserine, or other glycerophospholipids, ceramide, sphingolipid, sterol, fat-soluble vitamin, prenol, saccharolipid, polyketide, their salts and esters and the combination thereof.
Waxes in the context of the present invention are organic compounds that characteristically consist of long alkyl chains. Natural waxes (plant, animal) are typically esters of fatty acids and long chain alcohols. Synthetic waxes are long- chain hydrocarbons lacking functional groups. The encapsulating agent, as described herein may also be selected from, but not limited to, beeswax, candelilla wax, carnauba wax, spermaceti, paraffin wax, synthetic waxes and the combination thereof.
Preferred examples of fats suitable for the present invention are glycerine monostearate, stearic acid, hydrogenated cottonseed fat, hydrogenated palm fat and hydrogenated rapeseed fat, hydrogenated palm fat, hydrogenated soyabean fat,
hydrogenated sunflower fat, hydrogenated rapeseed fat, soya fat, palmitic acid. These compounds can be used as such or as mixtures.
As per one embodiment of the invention, non-colouring formulation may be comprised of 1% to 20% by weight of excipients, which are acceptable in food, nutraceutical, cosmetics and pharmaceutical industry. Excipients may facilitate the granulation of turmeric powder or its blend with curcumin extract. The excipient may also facilitate conversion of granule formulation in desired dosage form, suitable for administration.
These are commonly used ingredients in industry, and are selected from the group of, but not limited to, fillers, diluents, disintegrants, lubricants, binders, glidants, anti caking agents, stabilizers, surfactants, channelizing agents, vehicles, buffers, stabilizers, preservatives, acidifiers, alkalizers, complexing agents, gum bases, antioxidants, viscosity enhancers, plasticizers, coating materials, and the combination thereof.
The excipients may belong to the class such as polymeric, non-polymeric, swelling, non-swelling, pH dependent and pH independent additives. The non-colouring turmeric formulation, as described herein, may be comprised of about 1 to 20% by weight of additives, which are selected from natural, semi-synthetic or synthetic sources. More preferably, the formulation may be comprised of about 1 to 15% by weight of excipients.
The formulation may be comprised of diluents known in the art, but not limited to microcrystalline cellulose, silicified microcrystalline, cellulose, powdered cellulose, microfine cellulose, corn starch, rice bran extract, calcium phosphate, dibasic calcium phosphate, tribasic calcium phosphate, calcium sulfate, or mixtures thereof. The diluents may also be selected from glucose, lactose, sucrose, dextrose, fructose, compressible sugar, or mixtures thereof.
The binders may be selected from the group of cellulose derivatives such as hydroxypropylmethyl cellulose (HPMC), hydroxypropyl cellulose (HPC), ethylcellulose, carboxymethylcellulose (CMC), sodium CMC, potassium CMC, calcium CMC, methylcellulose, hydroxyethyl cellulose (HEC), microcrystalline
cellulose; polyvinylpyrrolidone (PVP), vinyl pyrrolidone-vinyl acetate copolymer, polyvinyl alcohol, starch, carbomer, gums like xanthan gum, guar gum, acacia, locust bean gum, alginates, or mixtures thereof.
The disintegrants may be selected from sodium starch glycolate, crospovidone, croscarmellose sodium, croscarmellose calcium, croscarmellose potassium, sodium carbonate, sodium hydrogen carbonate, calcium carbonate, starch, starch 1500, modified starch, pregelatinized starch, crosslinked carboxymethyl starch, sodium hydrogen carbonate, hydroxypropyl cellulose, sodium carboxymethylcellulose or mixtures thereof.
According to one embodiment of the invention, the formulation may be prepared by using blend of turmeric powder and curcumin extract, which can be prepared by mixing both the powder components well using a suitable blender and/or mixer. Turmeric powder may be mixed with curcumin extract in different ratios, ranging from 50:1 to 5:1, to give rise to different variants of the non-colouring turmeric formulation.
As per another embodiment of the invention, turmeric powder or its blend with curcumin extract can be granulated using at least one excipient, employing various granulation processes known in the art such as dry granulation, wet granulation, melt granulation, extrusion spheronization, coacervation, congealing, reverse wet granulation, steam granulation, freeze granulation, foam granulation and the like.
According to one embodiment of the invention, the granules may be prepared by single step or multi-step granulation, using various suitable granulation equipment such as rapid mixer granulator, liquid mixer granulator, oscillating granulator, ribbon mixer granulator, extrusion spheronizer, hot melt extruder, roller compactor, fluid bed granulator, which are generally used in food, nutraceutical, cosmetics or pharmaceutical industry.
More preferably, the formulation may be prepared by wet granulation process using a binder and the agglomerates can be dried and sieved through suitable sieve to get the granules of desired size. The granules may be treated with a non-polymeric encapsulating agent using controlled process conditions employing suitable coating
equipment such as tangential fluid bed dryer, fluidized bed processor, bottom spray fluid bed drier or top spray fluid bed drier, rotary plate drier with circular, elliptical and fish gill like holes, or employing blenders like ribbon blender or using pan coaters to get a non-colouring turmeric formulation.
Preferably, the formulation may be prepared by using a combination of at least one excipient and a non-polymeric encapsulating agent, wherein the excipient such as binder or diluent is used to convert the blend into agglomerates, which are converted in granules. The granules may be treated with non-polymeric fatty encapsulating agent using controlled conditions of heat, wherein the encapsulating agent is applied to fluidized granules in the form of fine droplets under the current of air, using suitable equipment. The encapsulating agent may be applied on granules in multiple unform layers to offer non-colouring property.
The formulation of the invention was evaluated for flow property, assay content, stability, non-colouring property, and microbial content. The formulation was also subjected to Scanning Electron Microscopy (SEM) characterization for structure elucidation of encapsulated granules, in order to check uniformity of coating on the granules.
The non-colouring turmeric granules, as described herein are prepared by using non- polymeric encapsulating agent, which acts as an effective seal coating agent. The coating may also offer very good protection from microbial load as the microbes can’t survive in fat medium at the temperature employed for the purpose of coating or encapsulation. The surface of granules may get stabilized during the process of encapsulation, resulting in considerable reduction in the microbial load, which might have got introduced from turmeric powder.
Granular formulation prepared by the process as described herein, retains the characteristic yellowish orange colour the active even after the granulation, but it exhibits non-colouring and non-dusting property. As per this property, the granules avoid staining and dusting of yellowish orange colour, while processing it in finished dosage form. The granular non-colouring formulation of turmeric powder as described herein exhibits excellent flow property and it may overcome process difficulties such
as bulk handling of turmeric powder and/or curcumin extract, and overcomes the problem of colour explosion and dusting characteristics, which may make the formulation production troublesome, expensive and time consuming because of complete change over cleaning required using organic solvents after manufacturing the batches.
The composition as described herein is prepared by using environment friendly solvent for granulation and a non-polymeric encapsulating agent. The granules prepared by this process overcome the tedious problems of staining of the equipment and other contact surfaces and therefore are useful for formulation into finished dosage forms.
The granular formulation, as described herein, can be used as directly compressible grade granules, which can be compressed in tablets, without adding any other excipient like diluent, filler or binder and the combination thereof. This property adds to the industrial usefulness of the formulation, for converting the granules in tablet dosage forms, by retaining the percentage of active constituent, without diluting if further by addition of any excipients for compression purpose.
The non-colouring granular formulation as described herein has various advantages with respect to industrial processing. The formulation is comprised of turmeric powder or the blend of turmeric powder and curcumin extract, which combines whole spectrum of active constituents present in turmeric powder and the curcumin extract, such as curcuminoids, turmeric oil, and fibres, thus offering additional benefits to the consumers. Turmeric oil may offer advantage with respect to enhanced solubility and absorption of the formulation in the body system. Non-colouring formulation of the invention can be converted into tablets, capsules and other dosage forms by using suitable excipients, processes and equipment employed in nutraceutical, pharmaceutical or food industry. The granules do not stain the equipment used in the processing, thus making the formulation process convenient and industrially useful.
This data is presented, along with illustration in the form of non-limiting examples in the patent specification.
Examples
Example 1: Non-colouring formulation comprising Turmeric powder: Curcumin extract (15:1)
*q.s. in the table indicates quantity sufficient.
Process for preparation:
Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend. The binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size. The turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 30-55° C to get light to dark yellowish orange colour product, which is free flowing and exhibits non-colouring property.
Example 2: Evaluation of non-colouring property of turmeric granule formulation
The non-colouring property of turmeric granules obtained by the process disclosed in example 1 was evaluated during the compression in tablet dosage form. The formulation, which was obtained in the form of directly compressible grade (DC
grade) granules was subjected to the process of continuous tabletting for about 4 hours in a single rotary, 16 station tablet compression machine using a caplet size punch, which is oval, standard concave and plain on both sides.
Various parameters such as weight variation, hardness, thickness, friability of the compressed tablets were evaluated as a part of in-process quality check (IPQC) and the results were tabulated in Table 2.
It was observed from Figure 1 that there was no staining or colouring of the equipment like dies, punches, punch guide, turret, or any other part of the tabletting machine, while the granules were subjected to the tablet compression process for almost 4 hours. Further, the formulation did not cause any dusting of the compression area or the contact parts, while it was being processed into tablet dosage form. Thus, the non colouring formulation of turmeric is industrially useful for converting the free-flowing granules in suitable compressible finished dosage forms.
Example 3: Stability study of granules of Example 1
Free flowing granules of Example 1 were subjected to accelerated stability study in a tri-laminated aluminium pouch and the assay evaluation was carried out using HPLC analysis to understand the content of active over 6 months at standard condition of
temperature and humidity. The granules were also evaluated for microbial load during stability study and the results of evaluation are tabulated in Table 3.
It was observed that the granules prepared by process of Example 1 were stable over 6 months, under accelerated stability conditions and also the microbial load of the formulation was within acceptable limits for all variety of microbes mentioned in the table.
Example 4: Non-colouring formulation comprising turmeric powder:
Curcumin extract (9:1)
Process for preparation:
Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend. The binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size. The turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C. The granules are compressed in tablets for evaluation of curcuminoid contents.
Evaluation of curcuminoid content in tablet comprising non-colouring turmeric granules
The curcuminoid content of the non-colouring turmeric granules of example 4 were evaluated by HPLC evaluation using a tetrahydrofuran : citric acid anhydrous buffer mobile phase. The solution of working standard and test sample were prepared in methanol and injected in the system for determining the content of total curcuminoids, curcumin, desmethoxy curcumin and bisdesmethoxy curcumin.
Table 5: HPLC determination of Curcuminoids in tablet formulation
Example 5: Non-colouring formulation comprising turmeric powder: turmeric extract (45:1)
Process for preparation:
The turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend. The binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size. The turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C.
Example 6: Non-colouring formulation comprising turmeric powder: curcumin extract (5:1)
Turmeric powder and curcumin extract are dry mixed in suitable blender equipment to obtain a uniform blend. The binder comprising of starch paste is introduced into the blend to obtain agglomerates. These are dried and screened through the sieve to obtain granules of the desired size. The turmeric granules are encapsulated using molten hydrogenated palm stearin fat in the pan coater at temperature of about 65-70° C.
Example 7: Evaluation of Coating Uniformity of Non-colouring Turmeric formulation
The turmeric granules are coated with molten hydrogenated palm fat solids using hot melt technique. The encapsulation may be carried out under the current of air by spraying fine droplets molten fat in a fluidized bed processor.
The images of the cross-section view of encapsulated turmeric granules, as seen through scanning electron microscope are disclosed in the Figure 2.
It is evident from Table 9 A to D that wall thickness of individual fat layers was measured in the range of 5.93 pm to 17.24 pm, thus average thickness was about 11.0 pm. The thickness measurement, as obtained from analysis of the images indicated
that the coating was uniform on turmeric granules, thus exhibits the encapsulation efficiency of the coating agent, which resulted in non-colouring turmeric formulation.
Example 8: Evaluation of non-colouring property of turmeric granules
The non-colouring property of the formulation, as described herein was evaluated by comparative study wherein, effect of both the granular formulation and unformulated turmeric blend (turmeric powder and curcumin extract mixture in the same ratio as used in the formulated non-colouring product) on contact surface and the difference in the extent of cleaning required during processing of both the product was checked using equipment plate, followed by visual observation and UV absorbance of rinse solution at 420nm.
Non-colouring turmeric granular formulation was spread evenly on a steel plate and the product was removed on the butter paper. The plate was rinsed with methanol and the rinsate was analysed using UV absorbance at 420 nm. The same procedure was repeated for unformulated turmeric blend formulation and the number of rinsates were analyzed using UV spectrophotometer.
It is evident from above photographs, visual observation and the analysis that the formulation of turmeric blend exhibits non-colouring property as compared to unformulated turmeric blend and the cleaning time required for the formulation is significantly less than that required for unformulated turmeric blend.
It was seen that formulated turmeric blend granules are 116 times less staining than unformulated turmeric blend powder. Also the formulation, as described herein needs maximum 2 times rinsing to clear off the contact surface, in comparison to 4 rinsing required for unformulated turmeric blend, in order to get zero reading for total curcuminoids on UV Spectrophotometer at 420 nm. Thus the non-colouring formulation requires less number of washings to clean the contact surfaces or the equipment, as compared to the unformulated turmeric blend powder, which required multiple cleaning cycles, in order to clean the contact surface and equipment, before switching over to another product in the processing area. Non-colouring turmeric formulation, as described herein is thus convenient to process, involves less time and cost for cleaning the equipment and switching over to another product. It does not stain the contact surfaces and avoids dusting in the formulation area, thus proves to be industrially useful. The formulation is free flowing and can be conveniently converted in suitable compressible and other dosage forms, as per requirement.
Claims
1. A non-colouring turmeric formulation, comprised of blend of turmeric powder and curcumin extract, at least one non-polymeric encapsulating agent and at least one excipient which is acceptable in nutraceutical, food, cosmetic and pharmaceutical industry.
2. The non-colouring turmeric formulation of claim 1, which is comprised of blend of turmeric powder and curcumin extract varying in the range of 50: 1 to 5:1.
3. The non-colouring turmeric formulation of claim 2, which is comprised of about 2 to 20% by weight of total curcuminoids.
4. The non-colouring turmeric formulation of claim 1, which is comprised of about 10 to 25% by weight of at least one non-polymeric encapsulating agent.
5. The non-colouring turmeric formulation of claim 4, which is comprised of at least one non-polymeric encapsulating agent selected from the group of lipids, fats, fatty acids, fatty alcohols, fatty acid esters, waxes, and the combination thereof.
6. The non-colouring turmeric formulation of claim 1, which is comprised of about 1 to 20% by weight of at least one excipient, which is acceptable in nutraceutical, food and pharmaceutical industry.
7. The non-colouring turmeric formulation of claim 6, which is comprised of at least one excipient, selected from the class of fillers, diluents, disintegrants, lubricants, binders, glidants, anti-caking agents, stabilizers, surfactants, channelizing agents, vehicles, buffers, stabilizers, preservatives, acidifiers, alkalizers, complexing agents, gum bases, antioxidants, viscosity enhancers, plasticizers, coating materials, and the combination thereof.
8. The process for preparation of non-colouring turmeric formulation, which is comprised of
• mixing well turmeric powder and curcumin extract in desired ratio, varying in the range of 50: 1 to 5: 1 to get a blend
• granulating the blend of turmeric powder and curcumin extract, using at least one excipient, which is acceptable in neutraceutical, food and pharmaceutical industry, to get the granules
• encapsulating the agglomerates with at least one non-polymeric encapsulating agent selected from the group of lipids, fats, fatty acids, fatty alcohols, fatty acid esters, waxes, and the combination thereof; using suitable equipment to get free flowing and non-colouring turmeric granules
• converting the granules in desired solid or semisolid dosage forms or filling the granules in sachets, capsules for convenient administration to the subjects.
9. The process of non-colouring turmeric formulation of claim 8, wherein the granules range in size from 100 microns to 900 microns.
10. The non-colouring turmeric formulation of claim 1, which does not stain the contact surfaces and does not cause dusting and impart any colouration to the equipment and the formulation area, while processing and converting into suitable dosage forms.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202021051211 | 2020-11-25 | ||
IN202021051211 | 2020-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022112959A1 true WO2022112959A1 (en) | 2022-06-02 |
Family
ID=81754023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2021/060910 WO2022112959A1 (en) | 2020-11-25 | 2021-11-24 | Non-colouring turmeric formulation and a process for preparation thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022112959A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2008DE01853A (en) * | 2008-08-05 | 2010-03-26 | Ind Swift Limited | |
US20170258743A1 (en) * | 2014-12-15 | 2017-09-14 | Aurea Biolabs Private Limited | A Process for Preparation of Bioavailable White Curcumin - A Unique Blend of Hydrogenated Curcuminoids |
US20180042858A1 (en) * | 2016-08-11 | 2018-02-15 | Akay Flavours & Aromatics Pvt Ltd. | Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof |
-
2021
- 2021-11-24 WO PCT/IB2021/060910 patent/WO2022112959A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2008DE01853A (en) * | 2008-08-05 | 2010-03-26 | Ind Swift Limited | |
US20170258743A1 (en) * | 2014-12-15 | 2017-09-14 | Aurea Biolabs Private Limited | A Process for Preparation of Bioavailable White Curcumin - A Unique Blend of Hydrogenated Curcuminoids |
US20180042858A1 (en) * | 2016-08-11 | 2018-02-15 | Akay Flavours & Aromatics Pvt Ltd. | Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tolun et al. | Microencapsulation of grape polyphenols using maltodextrin and gum arabic as two alternative coating materials: Development and characterization | |
US6689388B2 (en) | Microencapsulated delivery system for high viscosity fluids | |
Sansone et al. | Flavonoid microparticles by spray-drying: Influence of enhancers of the dissolution rate on properties and stability | |
Sansone et al. | Maltodextrin/pectin microparticles by spray drying as carrier for nutraceutical extracts | |
Papillo et al. | Cocoa hulls polyphenols stabilized by microencapsulation as functional ingredient for bakery applications | |
Pelissari et al. | Production of solid lipid microparticles loaded with lycopene by spray chilling: Structural characteristics of particles and lycopene stability | |
Chatterjee et al. | Comparative evaluation of the antioxidant efficacy of encapsulated and un-encapsulated eugenol-rich clove extracts in soybean oil: Shelf-life and frying stability of soybean oil | |
US20030228369A1 (en) | Process for conversion of high viscosity fluids and compositions thereof | |
US6020003A (en) | Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin | |
JP5560289B2 (en) | Natural colorants and methods | |
Tolun et al. | Effect of different microencapsulating materials and relative humidities on storage stability of microencapsulated grape pomace extract | |
EP1450628A1 (en) | Powder formulation comprising conjugated octadecapolyenic acids | |
CA3091105A1 (en) | Compositions from cacao pericarp and methods of producing and using them | |
US10363225B2 (en) | Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof | |
CN108434108A (en) | The L-AA composition of the colour stable of solid | |
WO2022112959A1 (en) | Non-colouring turmeric formulation and a process for preparation thereof | |
US9399020B2 (en) | Hydrophilic matrix beadlet compositions with enhanced bioavailability | |
Tabio-García et al. | Effectiveness of Opuntia ficus-indica mucilage as a carrier agent in microencapsulation of bioactive compounds of Amaranthus hypochondriacus var. Nutrisol | |
Bakr et al. | Formulation, Characterization and Antimicrobial efficacy of Aegle marmelos Essential oil nanogel | |
US20220265575A1 (en) | Non-staining curcuminoid composition | |
US20190357560A1 (en) | Compositions from cacao pericarp and methods of producing and using them | |
JP2018002695A (en) | Crystalline cellulose mixed powder, composition, and method for producing molding | |
CA2322028C (en) | Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders | |
CN112638399B (en) | Oral composition containing ingredient derived from Curcuma rhizome and capable of being chewed and/or dissolved in oral cavity | |
RU2789521C2 (en) | Solid dosage form of chinese lemongrass seeds and its production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21897282 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21897282 Country of ref document: EP Kind code of ref document: A1 |